Cincinnati, OH, United States of America

Catherine Cagiannos

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The University of Tennessee Research Foundation. Active years: 2012-2015.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Catherine Cagiannos

Introduction

Catherine Cagiannos is a notable inventor based in Cincinnati, OH (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of adhesive compositions for vascular grafts. With a total of 3 patents, her work focuses on enhancing the delivery of therapeutic agents in medical devices.

Latest Patents

Cagiannos's latest patents include innovative adhesive compositions designed for use as delivery vehicles on coatings applied to vascular grafts. These water-soluble polymeric adhesive compositions are crucial for the effective delivery of therapeutic agents in vivo. The use of drug-coated vascular grafts is demonstrated to inhibit restenosis or neointimal hyperplasia, as well as to prevent infection at the vascular graft site. Additionally, methods for forming the adhesive and creating the coated vascular grafts are disclosed in her patents.

Career Highlights

Catherine Cagiannos is affiliated with the University of Tennessee Research Foundation, where she continues to advance her research in biomedical applications. Her work has garnered attention for its potential to improve patient outcomes in vascular surgeries.

Collaborations

Cagiannos has collaborated with esteemed colleagues such as Omran R Abul-Khoudoud and Timothy Fabian, contributing to the advancement of her research and innovations.

Conclusion

Catherine Cagiannos exemplifies the impact of innovative thinking in the medical field. Her patents and research efforts are paving the way for improved therapeutic solutions in vascular graft applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…